Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PionEar Technologies is a private Harvard Wyss Institute spinout developing bioinspired medical devices for ear and hearing disorders. Its lead technology is a minimally invasive, anti-biofouling tympanostomy tube designed to improve drainage and enable more effective drug delivery to the middle and inner ear. The company’s broader platform applies proprietary conduit-like implant designs and liquid-infused, super-repellent biomaterials to reduce cell, pathogen, and biofluid adhesion in implanted tubes and shunts. PionEar appears to be an early-stage platform medical device company rather than a therapeutics developer, with activity centered on otology and implantable drainage/drug-delivery devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PionEar Technologies.